openPR Logo
Press release

Global Enoxaparin API Market Report: Innovations and Regional Analysis for 2024-2030 | Valuates Reports

11-26-2024 12:54 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Enoxaparin API Market Size

The global market for Enoxaparin API was estimated to be worth US$ 670 million in 2023 and is forecast to a readjusted size of US$ 1001.5 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030.

North American market for Enoxaparin API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-9M12983/Global_Enoxaparin_API_Industry_Research_Report_Growth_Trends_and_Competitive_Analysis_2022_2028

Asia-Pacific market for Enoxaparin API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Enoxaparin API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Enoxaparin API include Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG and ChemWerth, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

By Type
• Multi Vials
• Pre-Filled Syringes

By Application
• COVID-19
• Pulmonary Embolism
• Atrial Fibrillation

Key Companies
Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG, ChemWerth, Laboratorios Farmaceuticos ROVI SA, Gland Pharma Limited, Hanways Chempharma Co. Ltd, Changzhou Qianhong Biopharma, Shenzhen Hepalink Pharmaceutical Group

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-9M12983/global-enoxaparin-api-industry

Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Enoxaparin API Market Report: Innovations and Regional Analysis for 2024-2030 | Valuates Reports here

News-ID: 3756838 • Views:

More Releases from Valuates Reports

Software-Defined Everything (SDE) Market Size, Trends & Forecasts | Valuates Rep …
Software-Defined Everything (SDE) Market Software-defined everything (SDE) is an umbrella term for a number of technologies that are helping redefine IT. Currently, this group of technologies encompasses software-defined networking (SDN), software-defined storage (SDS), and software-defined data centers (SDDC). Each approach aims to abstract the operating environment from physical infrastructure, while automating the processes that manage the infrastructure. By freeing businesses from proprietary hardware and simplifying the provisioning and management of IT
AI Server Market Size, Trends & Forecasts | Valuates Reports
AI Server Market Size The global AI Server market is projected to grow from US$ 31720 million in 2024 to US$ 78810 million by 2030, at a Compound Annual Growth Rate (CAGR) of 16.4% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-24S15068/Global_AI_Server_Market_Research_Report_2023?utm_source=openpr&utm_medium=referral&utm_campaign=openpr_referral Major Trends The global AI server market is driven by several key factors, including the rising adoption of artificial intelligence across various industries, advancements in AI technology, and the increasing need for
Precision Air Conditioner Market Size, Trends & Forecasts | Valuates Reports
Precision Air Conditioner Market Size The global Precision Air Conditioner revenue was US$ 4926.8 million in 2022 and is forecast to a readjusted size of US$ 7815.6 million by 2029 with a CAGR of 6.8% during the forecast period (2023-2029). Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-38A15722/Global_and_India_Precision_Air_Conditioner_Market_Report_Forecast_2023_2029?utm_source=openpr&utm_medium=referral&utm_campaign=openpr_referral The key precision air conditioning manufacturers are Vertiv, Stulz, Daikin etc. Top 3 companies occupied about 30% market share. China is the largest market, with a share about 35%,
Non-Segregated Phase Bus Duct Market Set to Surge - Key Insights You Must Know
Non-Segregated Phase Bus Duct Market Non-segregated phase bus is an assembly of bus conductors with associated connections, joints, and insulating supports confined within a metal enclosure without interphase barriers. The global Non-Segregated Phase Bus Duct market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-21G10197/Global_Non_Segregated_Phase_Bus_Duct_Market_Insights_Forecast_to_2028?utm_source=openpr&utm_medium=referral&utm_campaign=openpr_referral North American market for Non-Segregated Phase Bus Duct

All 5 Releases


More Releases for Enoxaparin

Enoxaparin API Market Demand Driven by Healthcare Needs | Persistence Market Res …
✅ Market Overview: Trends, Statistics, and Growth Drivers The Enoxaparin API market has gained substantial momentum in recent years, largely fueled by a surge in global demand for anticoagulant therapies. Enoxaparin, a low molecular weight heparin (LMWH), is widely used in the treatment of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism, and acute coronary syndromes. Its inclusion in the World Health Organization's list of essential medicines underlines
Comprehensive Report on an Enoxaparin Manufacturing Plant Project: Cost and Reve …
Setting up an enoxaparin manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Enoxaparin Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing an enoxaparin manufacturing plant, covering
Enoxaparin Sodium APIs and Preparations Market 2024-2030: Global Trends, Key Ins …
Enoxaparin Sodium APIs and Preparations - Market Size The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium APIs and Preparations, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enoxaparin Sodium APIs and Preparations
Enoxaparin Sodium Market : Size, Share, Growth, Analysis, Key Players, Revenue, …
Enoxaparin Sodium Market Size The global Enoxaparin Sodium market was valued at US$ 3315 million in 2023 and is anticipated to reach US$ 5415 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-6L9458/Global_Enoxaparin_Sodium_Market_Insights_and_Forecast_to_2028 Enoxaparin Sodium Market Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of
Enoxaparin Sodium Market Revenue, Insights, Overview, Outlook, Analysis | Valuat …
Enoxaparin Sodium Market The global Enoxaparin Sodium market was valued at US$ 3044.5 million in 2022 and is anticipated to reach US$ 5354.7 million by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029. Get Free Research Report: https://reports.valuates.com/request/sample/QYRE-Auto-6L9458/Global_Enoxaparin_Sodium_Market_Insights_and_Forecast_to_2028 Enoxaparin Sodium Market Share Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in
Advancements in Enoxaparin: An Overview of Latest Developments and Trends
The global 𝗘𝗻𝗼𝘅𝗮𝗽𝗮𝗿𝗶𝗻 market is estimated to attain a valuation of by the end of 2031, states a study by Transparency Market Research (TMR). The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the Enoxaparin industry. The current and historical status of the market together with forecasted market size and trends are demonstrated in the assessment in